Home > MAGLi 43

molecules of the month

<< Back to May

MAGLi 43

Recent Publication

CNS penetrant, intraperitoneal, reversible MAGL inh

in vivo target engagement in brain but lack of efficacy

from opt. of a screening hit

bioRxiv

Roche, Basel, CH

Context. MAGLi 432 (Roche) is a novel, reversible monoacylglycerol lipase (MAGL) inhibitor. There has been increasing interest in the role of inflammation and blood-brain barrier dysfunction in neurology. The…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

MAGLi 43

this content is exclusive to Premium members

this content is exclusive to
Premium members